Pituitary surgery outcome in patients 75 years and older: a retrospective study

Acta Neurochir (Wien). 2023 Nov;165(11):3409-3420. doi: 10.1007/s00701-023-05809-x. Epub 2023 Sep 22.

Abstract

Background: As the population ages, the number of elderly patients with an indication for pituitary surgery is rising. Information on the outcome of patients aged over 75 is limited. This study reports a large series assessing the feasibility of surgical resection in this specific age range, focusing on surgical complications and postoperative results.

Methods: A retrospective cohort study of patients with pituitary adenomas and Rathke's cleft cysts was conducted. All patients were aged 75 years or over and treated by a single expert neurosurgical team. A control population included 2379 younger adult patients operated by the same surgeons during the same period.

Results: Between 2008 and 2022, 155 patients underwent surgery. Indication was based on vision impairment in most patients (79%). Median follow-up was 13 months (range: 3-96). The first surgery was performed with an endoscopic transsellar approach, an extended endonasal transtuberculum approach and a microscopic transcranial approach in 96%, 3%, and 1% of patients, respectively. Single surgery was sufficient to obtain volume control in 97% of patients. From Kaplan-Meier estimates, 2-year and 5-year disease control with a single surgery were 97.3% and 86.2%, respectively. Resection higher than 80% was achieved in 77% of patients. No vision worsening occurred. In acromegaly and Cushing's disease, endocrine remission was obtained in 90% of non-invasive adenomas. Surgical complications were noted in 5% of patients, with 30-day mortality, hematoma, cerebrospinal fluid leak, meningitis, and epistaxis occurring in 0.6%, 0.6%, 1.9%, 0.6%, and 1.3% respectively. New endocrine anterior deficits occurred in only 5%, while no persistent diabetes insipidus was noted. Compared with younger patients, the complication rate was not statistically different.

Conclusions: Surgery beyond the age of 75, mainly relying on an endoscopic endonasal transsellar approach, is effective and safe, provided that patients are managed in tertiary centers.

Keywords: Adenoma; Complications; Elderly; Endoscopy; PitNET; Pituitary surgery.

MeSH terms

  • Adenoma* / complications
  • Adenoma* / surgery
  • Adult
  • Aged
  • Endoscopy / methods
  • Humans
  • Neurosurgical Procedures / adverse effects
  • Neurosurgical Procedures / methods
  • Nose
  • Pituitary Neoplasms* / complications
  • Pituitary Neoplasms* / surgery
  • Postoperative Complications / epidemiology
  • Postoperative Complications / surgery
  • Retrospective Studies
  • Treatment Outcome